BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 27 found
  Current Search:  osteomyelitis: 27, bone: 2915     

HTML
68%
2/7/10 - Abaxis Receives FDA 510K Clearance for a New Clinical Assay, C-Reactive Protein
- (NewsRx.com) Abaxis, Inc.

(NASDAQ:ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced that the U.S.

Food and Drug Administration (FDA) has granted 510K marketing clearance of the new C-Reactive Protein (CRP)...

Pharmacy Choice:  Feb 7 2010 12:45PM
Matching: osteomyelitis
Find similar documents
HTML
68%
Abaxis Receives FDA 510K Clearance for a New Clinical Assay, C-Reactive Protein
Healthcare Professionals Now Have Access to Important Information on Inflammation, Infection and Tissue Injury at the Point-of-care.

UNION CITY, Calif., Jan.

21 /PRNewswire-FirstCall/ -- Abaxis, Inc.

(NASDAQ:ABAX) , a medical products company...

Pharma Live:  Jan 22 2010 3:08AM
Matching: osteomyelitis
Find similar documents
HTML
68%
Abaxis Receives FDA 510K Clearance for a New Clinical Assay, C-Reactive Protein
Healthcare Professionals Now Have Access to Important Information on Inflammation, Infection and Tissue Injury at the Point-of-care.

UNION CITY, Calif., Jan.

21 /PRNewswire-FirstCall/ -- Abaxis, Inc.

(NASDAQ:ABAX) , a medical products company...

Therapeutics Daily:  Jan 21 2010 10:45PM
Matching: osteomyelitis
Find similar documents
HTML
68%
1/21/10 - Abaxis Receives FDA 510K Clearance for a New Clinical Assay, C-Reactive Protein
UNION CITY, Calif., Jan.

21 /PRNewswire-FirstCall/ Abaxis, Inc.

(Nasdaq: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today announced that the U.S.

Food and Drug Administration (FDA) has granted 510K marketing...

Pharmacy Choice:  Jan 21 2010 9:22PM
Matching: osteomyelitis
Find similar documents
HTML
68%
Abaxis Receives FDA 510K Clearance for a New Clinical Assay, C-Reactive Protein
UNION CITY, Calif., Jan.

21 /PRNewswire-FirstCall/ Abaxis, Inc.

(Nasdaq: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today announced that the U.S.

Food and Drug Administration (FDA) has granted 510K marketing...

Pharmacy Choice:  Jan 21 2010 8:49PM
Matching: osteomyelitis
Find similar documents
HTML
68%
Abaxis' new CRP assay receives FDA marketing clearance
Abaxis, Inc.

(Nasdaq: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today announced that the U.S.

Food and Drug Administration (FDA) has granted 510K marketing clearance of the new C-Reactive Protein (CRP) assay when...

News-Medical.Net:  Jan 21 2010 1:12PM
Matching: osteomyelitis
Find similar documents
HTML
68%
Abaxis Receives FDA 510K Clearance for a New Clinical Assay, C-Reactive Protein
UNION CITY, Calif., Jan.

21 /PRNewswire-FirstCall/ -- Abaxis, Inc.

(Nasdaq: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today announced that the U.S.

Food and Drug Administration (FDA) has granted 510K marketing...

Genetic Engineering News:  Jan 21 2010 1:06PM
Matching: osteomyelitis
Find similar documents
HTML
68%
Abaxis Receives FDA 510K Clearance for a New Clinical Assay, C-Reactive Protein / U.S. Healthcare Professionals Now Have Access to Important Information on Inflammation, Infection and Tissue Injury at the Point-of-care.
UNION CITY, Calif., Jan.

21 /PRNewswire-FirstCall/ -- Abaxis, Inc.

, a medical products company manufacturing point-of-care blood analysis systems, today announced that the U.S.

Food and Drug Administration (FDA) has granted 510K marketing clearance of...

FinanzNachrichten.de:  Jan 21 2010 12:10PM
Matching: osteomyelitis
Find similar documents
HTML
68%
Jiangbos Osteomyelitis tablets to be included in China's Insurance Directory
Jiangbo ceuticals, a pharmaceutical company with its principal operations in China, announced that its Osteomyelitis treatment tablets (Kang Gu Sui Yan Pian) has been included in the 2009 Edition of the National Basic Medical Insurance, Industrial Injury...
Bio Spectrum Asia:  Jan 15 2010 6:36AM
Matching: osteomyelitis
Find similar documents
HTML
100%
Jiangbo Pharmaceuticals' treatment for bone marrow inflammation added to National Medical Insurance Directory
Jiangbo Pharmaceuticals (OTC: JGBO) (Jiangbo') expects to achieve meaningful sales volume growth following the inclusion of its traditional treatment for bone and bone marrow inflammations, or Osteomyelitis, in China's 2009 National Medical...
Proactive Investors.co.uk:  Jan 14 2010 11:07AM
Matching: osteomyelitis bone
Find similar documents
HTML
100%
Jiangbo Pharmaceuticals (JGBO.OB) Announces Inclusion of Its Osteomyelitis Treatment Tablets in the Chinese National Insurance Directory
Jiangbo Pharmaceuticals, Inc., a researcher, developer, producer and marketer of pharmaceutical products in China, recently announced that the companys Osteomyelitis treatment tablets have been included in the 2009 Edition of the National Basic Medical...
International Business Times:  Jan 14 2010 3:51PM
Matching: osteomyelitis bone
Find similar documents
HTML
100%
Jiangbo Pharmaceuticals expects sales growth as inflammation drug enters Chinese medical insurance d
Jiangbo Pharmaceuticals (OTC: JGBO) (Jiangbo) expects to achieve meaningful sales volume growth following the inclusion of its traditional treatment for bone and bone marrow inflammations, or Osteomyelitis, in Chinas 2009 National Medical...
Proactive Investors.co.uk:  Jan 13 2010 4:27PM
Matching: osteomyelitis bone
Find similar documents
HTML
100%
Jiangbo Pharmaceuticals' Osteomyelitis Treatment Tablets to be Included in China's National Insurance Director
See more news releases in: OTC, SmallCap, Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, Awards LAIYANG, China, Jan.

13 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc.

(OTC Bulletin Board: JGBO) (the 'Company' or ...

PR Newswire:  Jan 13 2010 1:11PM
Matching: osteomyelitis bone
Find similar documents
HTML
100%
Jiangbo Pharmaceuticals' Osteomyelitis Treatment Tablets to be Included in China's National Insurance Directory
LAIYANG, China, Jan.

13 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc.

(OTC Bulletin Board: JGBO.OB) (the "Company" or "Jiangbo"), a pharmaceutical company with its principal operations in China, today announced that its Osteomyelitis...

Yahoo! Canada:  Jan 13 2010 2:46PM
Matching: osteomyelitis bone
Find similar documents
HTML
100%
Jiangbo Pharmaceuticals' Osteomyelitis Treatment Tablets to be Included in China's National Insurance Directory
LAIYANG, China, Jan.

13 LAIYANG, China, Jan.

13 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc.

(OTC Bulletin Board: JGBO) (the "Company" or "Jiangbo"), a pharmaceutical company with its principal operations in China, today announced that its...

Nashville Business Journal:  Jan 13 2010 2:20PM
Matching: osteomyelitis bone
Find similar documents
HTML
100%
Jiangbo Pharmaceuticals' Osteomyelitis Treatment Tablets to be Included in China's National Insurance Directory
LAIYANG, China, Jan.

13 LAIYANG, China, Jan.

13 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc.

(OTC Bulletin Board: JGBO) (the "Company" or "Jiangbo"), a pharmaceutical company with its principal operations in China, today announced that its...

Kansas City Business Journal:  Jan 13 2010 2:20PM
Matching: osteomyelitis bone
Find similar documents
HTML
100%
Jiangbo Pharmaceuticals' Osteomyelitis Treatment Tablets to be Included in China's National Insurance Directory
LAIYANG, China, Jan.

13 LAIYANG, China, Jan.

13 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc.

(OTC Bulletin Board: JGBO) (the "Company" or "Jiangbo"), a pharmaceutical company with its principal operations in China, today announced that its...

Orlando Business Journal:  Jan 13 2010 2:14PM
Matching: osteomyelitis bone
Find similar documents
HTML
100%
Jiangbo Pharmaceuticals' Osteomyelitis Treatment Tablets to be Included in China's National Insurance Directory
LAIYANG, China, Jan.

13 LAIYANG, China, Jan.

13 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc.

(OTC Bulletin Board: JGBO) (the "Company" or "Jiangbo"), a pharmaceutical company with its principal operations in China, today announced that its...

Business Journal of Tampa Bay:  Jan 13 2010 1:51PM
Matching: osteomyelitis bone
Find similar documents
HTML
100%
Jiangbo Pharmaceuticals' Osteomyelitis Treatment Tablets to be Included in China's National Insurance Directory
LAIYANG, China, Jan.

13 LAIYANG, China, Jan.

13 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc.

(OTC Bulletin Board: JGBO) (the "Company" or "Jiangbo"), a pharmaceutical company with its principal operations in China, today announced that its...

Business Journal of Milwaukee:  Jan 13 2010 1:49PM
Matching: osteomyelitis bone
Find similar documents
HTML
100%
Jiangbo Pharmaceuticals' Osteomyelitis Treatment Tablets to be Included in China's National Insurance Directory
LAIYANG, China, Jan.

13 LAIYANG, China, Jan.

13 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc.

(OTC Bulletin Board: JGBO) (the "Company" or "Jiangbo"), a pharmaceutical company with its principal operations in China, today announced that its...

Business First of Buffalo:  Jan 13 2010 1:47PM
Matching: osteomyelitis bone
Find similar documents
HTML
100%
Jiangbo Pharmaceuticals' Osteomyelitis Treatment Tablets to be Included in China's National Insurance Directory
LAIYANG, China, Jan.

13 LAIYANG, China, Jan.

13 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc.

(OTC Bulletin Board: JGBO) (the "Company" or "Jiangbo"), a pharmaceutical company with its principal operations in China, today announced that its...

Dallas Business Chronicle:  Jan 13 2010 1:46PM
Matching: osteomyelitis bone
Find similar documents
HTML
100%
Jiangbo Pharmaceuticals' Osteomyelitis Treatment Tablets to be Included in China's National Insurance Directory
LAIYANG, China, Jan.

13 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc.

(BULLETIN BOARD: JGBO) (the "Company" or "Jiangbo"), a pharmaceutical company with its principal operations in China, today announced that its Osteomyelitis treatment...

FinanzNachrichten.de:  Jan 13 2010 1:11PM
Matching: osteomyelitis bone
Find similar documents
HTML
100%
Jiangbo Pharmaceuticals' Osteomyelitis Treatment Tablets to be
Jiangbo Pharmaceuticals, Inc.

(OTC Bulletin Board: JGBO) (the "Company" or "Jiangbo"), a pharmaceutical company with its principal operations in China, today announced that its Osteomyelitis treatment tablets (Kang Gu Sui Yan Pian) has been included in...

PR Newswire via MSN Money:  Jan 13 2010 1:17PM
Matching: osteomyelitis bone
Find similar documents
HTML
68%
Jiangbo Pharmaceuticals' Osteomyelitis Treatment Tablets to be Included in China's National Insurance Directory
Jiangbo Pharmaceuticals, Inc.

Jiangbo Pharmaceuticals' Osteomyelitis Treatment Tablets to be Included in China's National Insurance Directory.

Individual.com:  Jan 13 2010 1:20PM
Matching: osteomyelitis
Find similar documents
HTML
68%
Jiangbo Pharmaceuticals' Osteomyelitis Treatment Tablets to be Included in China's National Insurance Director
_ Jiangbo Pharmaceuticals' Osteomyelitis Treatment Tablets to be Included in China's National Insurance Director.
PR Newswire via Yahoo!:  Jan 13 2010 1:07PM
Matching: osteomyelitis
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.